Parallel probing of drug uptake of single cancer cells on a microfluidic device

Yoon Sun Yang, Severine le Gac, Leon Terstappen, Hoon Suk Rho (Corresponding Author)

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
2 Downloads (Pure)

Abstract

Drug resistance is frequently developing during treatment of cancer patients. Intracellular drug uptake is one of the important characteristics to understand mechanism of drug resistance. However, the heterogeneity of cancer cells requires the investigation of drug uptake at the single cell level. Here, we developed a microfluidic device for parallel probing of drug uptake. We combined a v-type valve and peristaltic pumping to select individual cells from a pool of prostate cancer cells (PC3) and place them successively in separate cell chambers in which they were exposed to the drug. Six different concentrations of doxorubicin, a naturally fluorescent anti-cancer drug, were created in loop-shaped reactors and exposed to the cell in closed 2 nL volume chambers. Monitoring every single cell over time in 18 parallel chambers revealed increased intracellular fluorescence intensity according to the dose of doxorubicin, as well as nuclear localization of the fluorescent drug after 2 h of incubation. The herein proposed technology demonstrated a first series of proof of concept experiments and it shows high potential to use for probing drug sensitivity of single cancer cell.
Original languageEnglish
Pages (from-to)548-556
Number of pages9
JournalElectrophoresis
Volume39
Issue number3
Early online date20 Dec 2017
DOIs
Publication statusPublished - 1 Feb 2018

Fingerprint

Lab-On-A-Chip Devices
Microfluidics
Cells
Pharmaceutical Preparations
Neoplasms
Drug Resistance
Doxorubicin

Keywords

  • UT-Hybrid-D
  • Microfluidics
  • Drug uptake
  • Single cell analysis

Cite this

@article{bb910d821bfb48edabbdbb486e981d43,
title = "Parallel probing of drug uptake of single cancer cells on a microfluidic device",
abstract = "Drug resistance is frequently developing during treatment of cancer patients. Intracellular drug uptake is one of the important characteristics to understand mechanism of drug resistance. However, the heterogeneity of cancer cells requires the investigation of drug uptake at the single cell level. Here, we developed a microfluidic device for parallel probing of drug uptake. We combined a v-type valve and peristaltic pumping to select individual cells from a pool of prostate cancer cells (PC3) and place them successively in separate cell chambers in which they were exposed to the drug. Six different concentrations of doxorubicin, a naturally fluorescent anti-cancer drug, were created in loop-shaped reactors and exposed to the cell in closed 2 nL volume chambers. Monitoring every single cell over time in 18 parallel chambers revealed increased intracellular fluorescence intensity according to the dose of doxorubicin, as well as nuclear localization of the fluorescent drug after 2 h of incubation. The herein proposed technology demonstrated a first series of proof of concept experiments and it shows high potential to use for probing drug sensitivity of single cancer cell.",
keywords = "UT-Hybrid-D, Microfluidics, Drug uptake, Single cell analysis",
author = "Yang, {Yoon Sun} and {le Gac}, Severine and Leon Terstappen and Rho, {Hoon Suk}",
note = "Wiley deal",
year = "2018",
month = "2",
day = "1",
doi = "10.1002/elps.201700351",
language = "English",
volume = "39",
pages = "548--556",
journal = "Electrophoresis",
issn = "0173-0835",
publisher = "Wiley-VCH Verlag",
number = "3",

}

Parallel probing of drug uptake of single cancer cells on a microfluidic device. / Yang, Yoon Sun; le Gac, Severine ; Terstappen, Leon; Rho, Hoon Suk (Corresponding Author).

In: Electrophoresis, Vol. 39, No. 3, 01.02.2018, p. 548-556.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Parallel probing of drug uptake of single cancer cells on a microfluidic device

AU - Yang, Yoon Sun

AU - le Gac, Severine

AU - Terstappen, Leon

AU - Rho, Hoon Suk

N1 - Wiley deal

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Drug resistance is frequently developing during treatment of cancer patients. Intracellular drug uptake is one of the important characteristics to understand mechanism of drug resistance. However, the heterogeneity of cancer cells requires the investigation of drug uptake at the single cell level. Here, we developed a microfluidic device for parallel probing of drug uptake. We combined a v-type valve and peristaltic pumping to select individual cells from a pool of prostate cancer cells (PC3) and place them successively in separate cell chambers in which they were exposed to the drug. Six different concentrations of doxorubicin, a naturally fluorescent anti-cancer drug, were created in loop-shaped reactors and exposed to the cell in closed 2 nL volume chambers. Monitoring every single cell over time in 18 parallel chambers revealed increased intracellular fluorescence intensity according to the dose of doxorubicin, as well as nuclear localization of the fluorescent drug after 2 h of incubation. The herein proposed technology demonstrated a first series of proof of concept experiments and it shows high potential to use for probing drug sensitivity of single cancer cell.

AB - Drug resistance is frequently developing during treatment of cancer patients. Intracellular drug uptake is one of the important characteristics to understand mechanism of drug resistance. However, the heterogeneity of cancer cells requires the investigation of drug uptake at the single cell level. Here, we developed a microfluidic device for parallel probing of drug uptake. We combined a v-type valve and peristaltic pumping to select individual cells from a pool of prostate cancer cells (PC3) and place them successively in separate cell chambers in which they were exposed to the drug. Six different concentrations of doxorubicin, a naturally fluorescent anti-cancer drug, were created in loop-shaped reactors and exposed to the cell in closed 2 nL volume chambers. Monitoring every single cell over time in 18 parallel chambers revealed increased intracellular fluorescence intensity according to the dose of doxorubicin, as well as nuclear localization of the fluorescent drug after 2 h of incubation. The herein proposed technology demonstrated a first series of proof of concept experiments and it shows high potential to use for probing drug sensitivity of single cancer cell.

KW - UT-Hybrid-D

KW - Microfluidics

KW - Drug uptake

KW - Single cell analysis

UR - http://www.scopus.com/inward/record.url?scp=85041480976&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/parallel-probing-drug-uptake-single-cancer-cells-microfluidic-device

U2 - 10.1002/elps.201700351

DO - 10.1002/elps.201700351

M3 - Article

VL - 39

SP - 548

EP - 556

JO - Electrophoresis

JF - Electrophoresis

SN - 0173-0835

IS - 3

ER -